Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.003 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.003 |